ADMA Biologics ADMA Stock Issued During Period Value Cashless Exercise Of Warrants
Stock Issued During Period Value Cashless Exercise Of Warrants at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept adma:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants.
The official record: ADMA Biologics’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's stock issued during period value cashless exercise of warrants.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's stock issued during period value cashless exercise of warrants?
- ADMA Biologics (ADMA) reported stock issued during period value cashless exercise of warrants of -$1K in Q4 2025.
- What does stock issued during period value cashless exercise of warrants mean?
- This metric tracks the value associated with the cashless exercise of warrants, where the holder receives shares without a direct cash payment to the company. It reflects the impact on equity and share count without generating immediate cash inflows.